Shafer Cynthia M, Lindvall Mika, Bellamacina Cornelia, Gesner Thomas G, Yabannavar Asha, Jia Weiping, Lin Song, Walter Annette
Oncology Division, Novartis Institutes of Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA.
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4482-5. doi: 10.1016/j.bmcl.2008.07.061. Epub 2008 Jul 17.
A series of 4-(4-hydroxyphenyl)-6-phenylpyrimidin-2(1H)-ones were identified by HTS as inhibitors of CDC7. Molecular modeling and medicinal chemistry techniques were employed to explore the SAR for this series with a focus on removing potential metabolic liabilities and improving cellular potency.
通过高通量筛选（HTS）鉴定出一系列4-（4-羟基苯基）-6-苯基嘧啶-2（1H）-酮为细胞周期蛋白依赖性激酶7（CDC7）的抑制剂。采用分子建模和药物化学技术探索该系列的构效关系（SAR），重点是消除潜在的代谢缺陷并提高细胞活性。
Zotero 插件